Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:John_Fowler
|
| gptkbp:developedBy |
novel small molecule therapeutics
|
| gptkbp:focusesOn |
oncology
autoimmune diseases |
| gptkbp:foundedYear |
2015
|
| gptkbp:founder |
gptkb:John_Fowler
Christopher Kirk Jack Taunton |
| gptkbp:headquartersLocation |
gptkb:South_San_Francisco,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Kezar Life Sciences
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:leadProductCandidate |
KZR-261
KZR-616 |
| gptkbp:publiclyTraded |
true
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:KZR
|
| gptkbp:website |
https://www.kezarlifesciences.com/
|
| gptkbp:bfsParent |
gptkb:KZR
gptkb:The_Column_Group |
| gptkbp:bfsLayer |
7
|